Lenoss Medical’s OsteoPearl procedure reached its 150th case, according to a March 27 news release shared with Becker’s.
More than half of the 150 cases were completed since September. OsteoPearl is an allograft designed to augment vertebral compression fractures. It provides a natural bone scaffold.
In 2024, Lenoss Medical closed $4 million in series A financing, and that money was used to accelerate commercialization.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
